Kenneth Hughes
Operationeel Directeur bij MICROBIX BIOSYSTEMS INC.
Vermogen: 106 015 $ op 31-05-2024
Actieve functies van Kenneth Hughes
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Operationeel Directeur | 03-06-2019 | - |
| Roker Biotechnologies, Inc. | Oprichter | 01-01-2010 | - |
| President | 01-01-2010 | - |
Loopbaan van Kenneth Hughes
Eerdere bekende functies van Kenneth Hughes
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Itp Biomedica Corp. | Algemeen Directeur | 01-01-2014 | 01-01-2019 |
| President | 01-01-2014 | 01-01-2019 | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 | 01-01-2013 |
| MICROBIX BIOSYSTEMS INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-1995 | 01-01-2010 |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Oprichter | 01-01-2008 | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - | - |
Opleiding van Kenneth Hughes
| The University of Sheffield | Undergraduate Degree |
| University of London | Doctorate Degree |
Statistieken
Internationaal
| Canada | 7 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| President | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
| Itp Biomedica Corp. | |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Health Technology |
| Roker Biotechnologies, Inc. |
- Beurs
- Insiders
- Kenneth Hughes
- Ervaring
